content-image
Science
00

Opening a new research avenue

Bringing together top-notch biology and particle physics, radioligand therapy offers a new avenue for medicine to broaden its arsenal for difficult-to-treat diseases such as cancer. The fledgling field, which has seen several new therapies reach the market in the past few years, could get another boost as Novartis opens its first fully dedicated nuclear medicine lab in Basel.

Text by Goran Mijuk, photos by Laurids Jensen and Bjoern Myhre

scroll-down
Home
en
de
zh
jp
Share
Share icon
Home
en
de
zh
jp
Share
Share icon